Differential global gene expression in cystic fibrosis nasal and bronchial epithelium

Genomics

Volumn 98, Issue 5, 2011, Pages 327-336

  Ogilvie, Varrie ^a,d   Passmore, Margaret ^a,d   Hyndman, Laura ^a,d   Jones, Lisa ^a,d   Stevenson, Barbara ^a,d   Wilson, Abigail ^a,d   Davidson, Heather ^a,d   Kitchen, Robert R ^a   Gray, Robert D ^a,d   Shah, Pallav ^b,c   Alton, Eric W ^b,d   Davies, Jane C ^b,c,d   Porteous, David J ^a,d   Boyd, A Christopher ^a,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UK Cystic Fibrosis Gene Therapy Consortium   (United Kingdom)

Author keywords

Cystic fibrosis; Global gene expression; Respiratory epithelium

Indexed keywords

AMINO ACID METABOLISM; ARTICLE; BRONCHUS MUCOSA; CELL GROWTH; CELL MOTION; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MICROARRAY ANALYSIS; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; BRONCHI; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINS; MALE; NASAL MUCOSA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 80055096007     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2011.06.008     Document Type: Article

References (45)

1. Bear C.E., Li C.H., Kartner N., Bridges R.J., Jensen T.J., Ramjeesingh M., Riordan J.R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992, 68:809-818.
2. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. [erratum appears in Science 1989 Sep 29;245(4925):1437]. Science 1989, 245:1066-1073.
3. Welsh M.J., Smith A.E. Cystic fibrosis. Sci. Am. 1995, 273:52-59.
4. Knowles M., Gatzy J., Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 1981, 305:1489-1495.
5. Gill D.R., Southern K.W., Mofford K.A., Seddon T., Huang L., Sorgi F., Thomson A., MacVinish L.J., Ratcliff R., Bilton D., Lane D.J., Littlewood J.M., Webb A.K., Middleton P.G., Colledge W.H., Cuthbert A.W., Evans M.J., Higgins C.F., Hyde S.C. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 1997, 4:199-209.
6. Galvin P., Clarke L.A., Harvey S., Amaral M.D. Microarray analysis in cystic fibrosis. J. Cyst. Fibros. 2004, 3(Suppl. 2):29-33.
7. Xu Y., Clark J.C., Aronow B.J., Dey C.R., Liu C., Wooldridge J.L., Whitsett J.A. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J. Biol. Chem. 2003, 278:7674-7682.
8. Zabner J., Scheetz T.E., Almabrazi H.G., Casavant T.L., Huang J., Keshavjee S., McCray P.B. CFTR DeltaF508 mutation has minimal effect on the gene expression profile of differentiated human airway epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L545-L553.
9. Wright J.M., Merlo C.A., Reynolds J.B., Zeitlin P.L., Garcia J.G., Guggino W.B., Boyle M.P. Respiratory epithelial gene expression in patients with mild and severe cystic fibrosis lung disease. Am. J. Respir. Cell Mol. Biol. 2006, 35:327-336.
10. Welch C., Santra M.K., El-Assaad W., Zhu X., Huber W.E., Keys R.A., Teodoro J.G., Green M.R. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res. 2009, 69:6782-6789.
11. Branton M.H., Kopp J.B. TGF-beta and fibrosis. Microbes Infect. 1999, 1:1349-1365.
12. Hajishengallis G., Wang M., Liang S., Triantafilou M., Triantafilou K. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc. Natl Acad. Sci. U. S. A. 2008, 105:13532-13537.
13. Cole L.W., Sidis Y., Zhang C., Quinton R., Plummer L., Pignatelli D., Hughes V.A., Dwyer A.A., Raivio T., Hayes F.J., Seminara S.B., Huot C., Alos N., Speiser P., Takeshita A., Van Vliet G., Pearce S., Crowley W.F., Zhou Q.Y., Pitteloud N. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J. Clin. Endocrinol. Metab. 2008, 93:3551-3559.
14. Tabary O., Zahm J.M., Hinnrasky J., Couetil J.P., Cornillet P., Guenounou M., Gaillard D., Puchelle E., Jacquot J. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am. J. Pathol. 1998, 153:921-930.
15. Gray R.D., MacGregor G., Noble D., Imrie M., Dewar M., Boyd A.C., Innes J.A., Porteous D.J., Greening A.P. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am. J. Respir. Crit. Care Med. 2008, 178:444-452.
16. Porter D., Lahti-Domenici J., Torres-Arzayus M., Chin L., Polyak K. Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues. Mech. Dev. 2002, 114:201-204.
17. Connon C.J., Kawasaki S., Yamasaki K., Quantock A.J., Kinoshita S. The quantification of hCLCA2 and colocalisation with integrin beta4 in stratified human epithelia. Acta Histochem. 2005, 106:421-425.
18. Walia V., Ding M., Kumar S., Nie D., Premkumar L.S., Elble R.C. hCLCA2 is a p53-inducible inhibitor of breast cancer cell proliferation. Cancer Res. 2009, 69:6624-6632.
19. Alexandre M.D., Lu Q., Chen Y.H. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J. Cell Sci. 2005, 118:2683-2693.
20. Pazgier M., Hoover D.M., Yang D., Lu W., Lubkowski J. Human beta-defensins. Cell. Mol. Life Sci. 2006, 63:1294-1313.
21. Rho J.H., Roehrl M.H., Wang J.Y. Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J. Proteome Res. 2009, 8:5610-5618.
22. Tochio T., Tanaka H., Nakata S., Hosoya H. Fructose-1,6-bisphosphate aldolase A is involved in HaCaT cell migration by inducing lamellipodia formation. J. Dermatol. Sci. 2010, 58:123-129.
23. Baulieu E.-E., Kelly P. Hormones: from molecules to disease 1990, Hermann, Chapman and Hall, New York and London.
24. Wang X., Wang Q., Ives K.L., Evers B.M. Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin. Cancer Res. 2006, 12:5346-5355.
25. Deiss L.P., Galinka H., Berissi H., Cohen O., Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 1996, 15:3861-3870.
26. Kirchner J., Bevan M.J. ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes. J. Exp. Med. 1999, 190:217-228.
27. Guo L., Lobenhofer E.K., Wang C., Shippy R., Harris S.C., Zhang L., Mei N., Chen T., Herman D., Goodsaid F.M., Hurban P., Phillips K.L., Xu J., Deng X., Sun Y.A., Tong W., Dragan Y.P., Shi L. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol. 2006, 24:1162-1169.
28. Alton E.W., Rogers D.F., Logan-Sinclair R., Yacoub M., Barnes P.J., Geddes D.M. Bioelectric properties of cystic fibrosis airways obtained at heart-lung transplantation. Thorax 1992, 47:1010-1014.
29. Knowles M.R., Carson J.L., Collier A.M., Gatzy J.T., Boucher R.C. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am. Rev. Respir. Dis. 1981, 124:484-490.
30. Welsh M.J.T., L-C, Boat T.F., Beaudet A.L. Cystic Fibrosis 1995, McGraw-Hill, New York.
31. McShane D., Davies J.C., Wodehouse T., Bush A., Geddes D., Alton E.W. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect. Eur. Respir. J. 2004, 24:95-100.
32. Adib-Conquy M., Pedron T., Petit-Bertron A.F., Tabary O., Corvol H., Jacquot J., Clement A., Cavaillon J.M. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol. Med. 2008, 14:36-44.
33. Newburger P.E., Subrahmanyam Y.V., Weissman S.M. Global analysis of neutrophil gene expression. Curr. Opin. Hematol. 2000, 7:16-20.
34. Groneberg D.A., Eynott P.R., Oates T., Lim S., Wu R., Carlstedt I., Nicholson A.G., Chung K.F. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir. Med. 2002, 96:81-86.
35. Hays S.R., Fahy J.V. Characterizing mucous cell remodeling in cystic fibrosis: relationship to neutrophils. Am. J. Respir. Crit. Care Med. 2006, 174:1018-1024.
36. Henke M.O., Renner A., Huber R.M., Seeds M.C., Rubin B.K. MUC5AC and MUC5B mucins are decreased in cystic fibrosis airway secretions. Am. J. Respir. Cell Mol. Biol. 2004, 31:86-91.
37. Davies J., Davies G., Voase N., Hyde S., Innes A., AC B., et al. Evaluation of safety and gene expression with a single dose of pGM169/GL67A administered to the nose and lung of individuals with cystic fibrosis: the UK Cystic Fibrosis Gene Therapy Consortium "pilot study". Thorax 2009, 64(Supplement IV):A70.
38. Taylor K.J., Sims A.H., Liang L., Faratian D., Muir M., Walker G., Kuske B., Dixon J.M., Cameron D.A., Harrison D.J., Langdon S.P. Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast Cancer Res. 2010, 12:R39.
39. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., Durie P.R., Legrys V.A., Massie J., Parad R.B., Rock M.J., Campbell P.W. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J. Pediatr. 2008, 153:S4-S14.
40. Davidson H., McLachlan G., Wilson A., Boyd A.C., Doherty A., MacGregor G., Davies L., Painter H.A., Coles R., Hyde S.C., Gill D.R., Amaral M.D., Collie D.D., Porteous D.J., Penque D. Human-specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways. Am. J. Respir. Cell Mol. Biol. 2006, 35:72-83.
41. Webster P., Vanacore L., Nairn A.C., Marino C.R. Subcellular localization of CFTR to endosomes in a ductal epithelium. Am. J. Physiol. 1994, 267:C340-C348.
42. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. Article3.
43. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. U. S. A. 2001, 98:5116-5121.
44. Team R.D.C. R: A language and environment for statistical computing 2010.
45. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.